Jeremy Bender, Chief Executive Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 3,104 shares at $13.12 ($41K) on 2023-05-16, disclosed to the SEC on 2023-05-17.
Open-market sale of $41k DAWN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |